Synthesis and pharmacological screening of some N-(4-substituted-piperazin-1-ylalkyl)-3,4-pyrroledicarboximides

Farmaco

Volumn 54, Issue 6, 1999, Pages 390-401

  Malinka, Wieslaw ^a   Sieklucka Dziuba, Maria ^b   Rajtar, Grazyna ^b   Rubaj, Andrzej ^b   Kleinrok, Zdzislaw ^b  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

3,4 Pyrroledicarboximide derivatives; Analgesic activity

Indexed keywords

ANALGESIC AGENT; PIPERAZINE DERIVATIVE; PYRROLE DERIVATIVE;

ACUTE TOXICITY; ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ARTERIAL PRESSURE; ARTICLE; CONTROLLED STUDY; DRUG SCREENING; DRUG SYNTHESIS; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOTOR COORDINATION; MOUSE; NONHUMAN; REACTION ANALYSIS; STRUCTURE ACTIVITY RELATION;

ANALGESICS, NON-NARCOTIC; ANIMALS; ANTI-ANXIETY AGENTS; ANTICONVULSANTS; BEHAVIOR, ANIMAL; BLOOD PRESSURE; CHEMISTRY, PHYSICAL; ELECTROSHOCK; FEMALE; LETHAL DOSE 50; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MICE; MOTOR ACTIVITY; MUSCULOSKELETAL EQUILIBRIUM; PAIN MEASUREMENT; PIPERAZINES; RATS; RATS, WISTAR;

EID: 0033617971     PISSN: 0014827X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-827X(99)00045-2     Document Type: Article

References (30)

1. Herndon J.L., Glennon R.A. Kozikowski A.P. Drug Design for Neuroscience. 1993;167-212 Raven Press, New York.
2. New J.S. The discovery and development of buspirone: a new approach to the treatment of anxiety, Med. Res. Rev. 10:1990;283-326.
3. Abou-Gharbia M., Moyer J.A., Patel U., Webb M., Schiehser G., Andree T., Haskins J.T. Synthesis and structure-activity relationship of substituted tetrahydro- and hexahydro-1,2-benzisothiazol-3-one 1,1-dioxides and thiadiazinones: potential anxiolytic agents. J. Med. Chem. 32:1989;1024-1033.
4. The Merck Index, 12th ed., Merck & Co., Inc., 1996.
5. Caliendo G., Di Carlo R., Meli R., Perissutti E., Santagada V., Silipo C., Vittoria A. Synthesis andtrazodone-like pharmacological profile of 1- and 2-[3-[4-(X)-1-piperazinyl]-propyl]-benzotriazoles. Eur. J. Med. Chem. 28:1993;969-974.
6. Mokrosz J., Duszyńska B., Paluchowska M., Charakchieva-Minol S., Mokrosz A. A search for new trazodone-like antidepressants: synthesis and preliminary receptor binding studies. Arch. Pharm. 328:1995;623-625.
7. Caliendo G., Di Carlo R., Greco G., Meli R., Novellino E., Perissutti E., Santagada V. Synthesis and biological activity of benzotriazole derivatives structurally related to trazodone. Eur. J. Med. Chem. 30:1995;77-84.
8. Yevich J.P., New J.S., Smith D.W., Lobeck W.G., Catt J.D., Minielli J.L., Eison M.S., Taylor D.P., Riblet L.A., Temple D.L. Jr. Synthesis and biological evaluation of 1-(1,2-benzoisothiazol-3-yl)- and (1,2-benaisoxazol-3-yl)piperazine derivatives as potential antipsychotic agents. J. Med. Chem. 29:1986;359-369.
9. Norman M.H., Minick D.J., Rigdon G.C. Effect of linking bridge modification on the antipsychotic profile of some phthalimide and isoindolinone derivatives. J. Med. Chem. 39:1996;149-157.
10. New J.S., Yevich J.P., Temple D.L. Jr., New K.B., Gross S.M., Schlemmer R.F. Jr., Eison M.S., Taylor D.P., Riblet L.A. Atypical antipsychotic agents: patterns of activity in a series of 3-substituted 2-pyridinyl-1-piperazine derivatives. J. Med. Chem. 31:1988;618-624.
11. Borison R.L., Sinha D., Haverstock S., McLarnon M.C., Diamond B.I. Efficacy and safety of tiospirone vs. haloperidol and thioridazine in a double-blind, placebo-controlled trial. Psychopharmacol. Bull. 25:1989;190-193.
12. Hrib N.J., Jurcak J.G., Huger F.P., Errico C.L., Dunn R.W. Synthesis and biological evaluation of a series of substituted N-alkoxyimides and -amides as potential atypical antipsychotic agents. J. Med. Chem. 34:1991;1068-1072.
13. 2 antagonistic action. Jpn. J. Pharmacol. 53:1990;321-329.
14. Rubat C., Coudert P., Albuisson E., Bastide J., Couquelet J., Tronche P. Synthesis of Mannich bases of arylidenepyridazinones as analgesic agents. J. Pharm. Sci. 81:1992;1084-1087.
15. Flouzat C., Bresson Y., Mattio A., Bonnet J., Guillaumet G. Novel nonopioid non-antiinflammatory analgesics: 3-(aminoalkyl)- and 3-[(4-aryl-1-piperazinyl)alkyl]oxazolo[4,5-b]pyridin-2(3H)-ones. J. Med. Chem. 36:1993;497-503.
16. Pugsley T.A., Myers S.M., Shih Y.H. Effects of CI-926 (3-[4-[4-(3-methylphenyl)-1-piperazinyl]butyl]-2,4-imidazolidinedione), an antihypertensive agent, on rat brain catecholamine and serotonin turnover. J. Cardiovasc. Pharmacol. 13:1989;455-464.
17. Malinka W., Rutkowska M. Synthesis and anorectic activity of 2H-4,6-dimethyl-2-[(4-phenylpiperazin-1-yl)methyl-3-oxo-2,3- dihydroisothiazolo[5,4-b]pyridine. Farmaco. 52:1997;595-601.
18. Malinka W., Tatarczyńska E. Synthesis and pharmacological properties of N-(4-substituted-1-piperazinylalkyl)-1-butyl-2,5-dimethylpyrrole-3,4- dicarboxyimide derivatives. Farmaco. 48:1993;933-947.
19. Malinka W., Sieklucka-Dziuba M., Robak J., Kleinrok Z. Synthesis and biological evaluation of derivatives of N-[4-substituted-1-piperazinylalkyl]-1-(butyl,aryl)-2,5-dimethylpyrrole-3,4- dicarboxyimide (Part II). Farmaco. 49:1994;481-487.
20. 1-adrenergic affinity. J. Med. Chem. 34:1991;2633-2638.
21. Malinka W., Bodalski T. Synthesis of some 1-substituted-2,5-dimethylpyrrole-3,4-dicarbixyimides from α,β-diacetylsuccinate. Pol. J. Chem. 68:1994;297-307.
22. Pollard C., Lauter W., Nuessle N. Derivatives of piperazine. XXXIV. Some reactions of trimethylene chlorobromide with 1-arylpiperazines. J. Org. Chem. 24:1959;764-767.
23. Litchfield I.T., Wilcoxon F. A simplified method of evaluating dose-effect experiments. J. Pharmacol. Exp. Ther. 96:1949;99-113.
24. Gross F., Tripod J., Meier R. Zur pharmakologischen Charakterisierung des Schlafmittels Doriden. Med. Wschr. 85:1955;305-309.
25. Koster R., Anderson M., de Bear E.J. Acetic acid for analgesic screening. Fed. Proc. 18:1959;412.
26. Eddy N.B., Leinbach D. Synthetic analgesics II. Dithienyl-butenyl and dithienyl-butylamines. J. Pharmacol. Exp. Ther. 107:1953;385-389.
27. Aron C., Simon D., Larousse C., Boissier J.R. Evaluation of a rapid technique for detecting minor tranquilizers. Neuropharmacology. 10:1971;459-469.
28. Swinyard E.A., Brown W.C., Goodman L.S. Comparative assays of antiepileptic drugs in mice and rats. J. Pharmacol. Exp. Ther. 106:1952;319-330.
29. Nakamura M., Fukushima H. Effects of reserpine, parachlorophenylalanine, 5,6-dihydroxytryptamine and fludiazepam on head twitches induced by 5-hydroxytryptamine or 5-methoxytryptamine in mice. J. Pharm. Pharmacol. 30:1978;254-256.
30. Gerold M., Tschirky H. Measurement of blood pressure in unanaesthetized rats. Artzneimittelforschung. 18:1968;1285-1287.